Jefferies sees huge upside potential in these two stocks

Analysts at Jefferies have identified two smaller biotech companies that could see their stocks appreciate significantly in the coming years. With policy changes in the US, such as expected deregulation and lower corporate taxation, there are new opportunities for growth and investment in the biotech sector.

Which 2 stocks are involved? 👇

Two of these companies, Metagenomi and Structure Therapeutics, are leveraging advanced technologies and are on the cusp of major breakthroughs in their research, according to Jefferies analysts. With the anticipation of regulatory loosening and a potential surge in biotech investment, these stocks appear to be promising opportunities for investors looking for high growth potential in the coming years. In this article, we look at the key projects of these companies and their prospects for success in the field of biotech innovation.